$ELV
Elevance Health, Inc. Stock $elv

$elv Overview Financials Valuation SEC Filings Company Website

2012 Q2 Form 10-Q Financial Statement

#000119312512313785 Filed on July 25, 2012

Income Statement

Concept	2012 Q2	2011 Q2
Revenue	$15.40B	$15.10B
YoY Change	1.96%	4.6%
Cost Of Revenue	$6.700M	$0.00
YoY Change
Gross Profit	$15.39B	$15.10B
YoY Change	1.91%
Gross Profit Margin	99.96%	100.0%
Selling, General & Admin	$2.082B	$2.011B
YoY Change	3.52%	-6.68%
% of Gross Profit	13.53%	13.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$181.0M	$155.0M
YoY Change	16.77%	6.16%
% of Gross Profit	1.18%	1.03%
Operating Expenses	$2.082B	$2.011B
YoY Change	3.52%	-84.77%
Operating Profit	$991.7M	$946.7M
YoY Change	4.75%
Interest Expense	$117.6M	$103.6M
YoY Change	13.51%	-203.6%
% of Operating Profit	11.86%	10.94%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.049B	$1.007B
YoY Change	4.1%	-10.85%
Income Tax	$405.0M	$305.8M
% Of Pretax Income	38.62%	30.36%
Net Earnings	$643.6M	$701.6M
YoY Change	-8.27%	-2.83%
Net Earnings / Revenue	4.18%	4.65%
Basic Earnings Per Share	$1.96	$1.92
Diluted Earnings Per Share	$1.94	$1.89
COMMON SHARES
Basic Shares Outstanding	327.7M shares	366.1M shares
Diluted Shares Outstanding	331.2M shares	371.5M shares

Balance Sheet

Concept	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.16B
YoY Change
Cash & Equivalents	$1.953B	$1.700B
Short-Term Investments	$17.21B
Other Short-Term Assets	$1.914B
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$28.47B	$1.158B
YoY Change	2358.56%	-12.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.478B	$1.213B
YoY Change	21.88%	3.59%
Goodwill	$14.53B
YoY Change
Intangibles	$8.126B
YoY Change
Long-Term Investments	$19.83B	$19.06B
YoY Change	4.02%	8.03%
Other Assets	$458.6M	$1.158B
YoY Change	-60.4%	-1.7%
Total Long-Term Assets	$26.06B	$49.72B
YoY Change	-47.58%	1.81%
TOTAL ASSETS
Total Short-Term Assets	$28.47B	$1.158B
Total Long-Term Assets	$26.06B	$49.72B
Total Assets	$54.54B	$50.88B
YoY Change	7.19%	1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.789B	$2.600B
YoY Change	7.27%	-1.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$200.0M	$100.0M
YoY Change	100.0%	0.0%
Long-Term Debt Due	$813.7M	$456.0M
YoY Change	78.44%	-59.07%
Total Short-Term Liabilities	$16.18B	$4.076B
YoY Change	296.9%	-16.13%
LONG-TERM LIABILITIES
Long-Term Debt	$10.14B	$8.292B
YoY Change	22.23%	13.05%
Other Long-Term Liabilities	$1.013B	$3.297B
YoY Change	-69.27%	-7.85%
Total Long-Term Liabilities	$11.15B	$11.59B
YoY Change	-3.8%	6.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.18B	$4.076B
Total Long-Term Liabilities	$11.15B	$11.59B
Total Liabilities	$30.89B	$26.70B
YoY Change	15.71%	1.24%
SHAREHOLDERS EQUITY
Retained Earnings	$12.22B
YoY Change
Common Stock	$3.200M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.64B	$24.18B
YoY Change
Total Liabilities & Shareholders Equity	$54.54B	$50.88B
YoY Change	7.19%	1.43%

Cashflow Statement

Concept	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	$643.6M	$701.6M
YoY Change	-8.27%	-2.83%
Depreciation, Depletion And Amortization	$181.0M	$155.0M
YoY Change	16.77%	6.16%
Cash From Operating Activities	$522.0M	$772.0M
YoY Change	-32.38%	201.56%
INVESTING ACTIVITIES
Capital Expenditures	-$102.0M	-$105.0M
YoY Change	-2.86%	1.94%
Acquisitions
YoY Change
Other Investing Activities	-$1.885B	-$648.0M
YoY Change	190.9%	58.44%
Cash From Investing Activities	-$1.987B	-$752.0M
YoY Change	164.23%	46.88%
FINANCING ACTIVITIES
Cash Dividend Paid	$93.50M	$91.10M
YoY Change	2.63%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.142B	-723.0M
YoY Change	-257.95%	-41.65%
NET CHANGE
Cash From Operating Activities	522.0M	772.0M
Cash From Investing Activities	-1.987B	-752.0M
Cash From Financing Activities	1.142B	-723.0M
Net Change In Cash	-323.0M	-703.0M
YoY Change	-54.05%	-52.98%
FREE CASH FLOW
Cash From Operating Activities	$522.0M	$772.0M
Capital Expenditures	-$102.0M	-$105.0M
Free Cash Flow	$624.0M	$877.0M
YoY Change	-28.85%	144.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Trading Symbol TradingSymbol	WLP
	dei	Document Type DocumentType	10-Q
	dei	Entity Registrant Name EntityRegistrantName	WellPoint, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001156039
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	325186630	shares
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1953100000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	17206100000	USD
CY2012Q2	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1139400000	USD
CY2012Q2	us-gaap	Other Short Term Investments OtherShortTermInvestments	16000000	USD
CY2012Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	164900000	USD
CY2012Q2	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3890700000	USD
CY2012Q2	us-gaap	Other Receivables OtherReceivables	935500000	USD
CY2012Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	137400000	USD
CY2012Q2	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	765900000	USD
CY2012Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	347500000	USD
CY2012Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1913600000	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	28470100000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	247100000	USD
CY2012Q2	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	29100000	USD
CY2012Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	1191200000	USD
CY2012Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10135600000	USD
CY2012Q2	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	696100000	USD
CY2012Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2868400000	USD
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1013300000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1478400000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	14534300000	USD
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8126200000	USD
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	458600000	USD
CY2012Q2	us-gaap	Assets Assets	54535000000	USD
CY2012Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	5415900000	USD
CY2012Q2	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	61800000	USD
CY2012Q2	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2277300000	USD
CY2012Q2	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	7755000000	USD
CY2012Q2	us-gaap	Unearned Premiums UnearnedPremiums	1707800000	USD
CY2012Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2788500000	USD
CY2012Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	813700000	USD
CY2012Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1958300000	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16177800000	USD
CY2012Q2	us-gaap	Liabilities Liabilities	30891200000	USD
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	3200000	USD
CY2012Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11204400000	USD
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12224000000	USD
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	212200000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	23643800000	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54535000000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2201600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	15913100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1188100000	USD
CY2011Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	14800000	USD
CY2011Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	172000000	USD
CY2011Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3402900000	USD
CY2011Q4	us-gaap	Other Receivables OtherReceivables	943900000	USD
CY2011Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	105800000	USD
CY2011Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	871400000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	424800000	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1859000000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	27097400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	246800000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	28800000	USD
CY2011Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1103300000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1418100000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	13858700000	USD
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7931700000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	433600000	USD
CY2011Q4	us-gaap	Assets Assets	52118400000	USD
CY2011Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	5489000000	USD
CY2011Q4	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	55100000	USD
CY2011Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2278200000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	7822300000	USD
CY2011Q4	us-gaap	Unearned Premiums UnearnedPremiums	926500000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3124100000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1274500000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1727100000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15898700000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8420900000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	730700000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2724000000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1055900000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	28830200000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	3400000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11679200000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11490700000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114900000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	23288200000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52118400000	USD
CY2012Q2	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	847200000	USD
CY2012Q2	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	241600000	USD
CY2012Q2	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	26800000	USD
CY2012Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2012Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	325159845	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	325159845	shares
CY2011Q4	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	937700000	USD
CY2011Q4	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	240800000	USD
CY2011Q4	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	28400000	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	339372680	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	339372680	shares
CY2012Q2	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	188100000	USD
CY2012Q2	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	766400000	USD
CY2012Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	200000000	USD
CY2011Q4	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	51700000	USD
CY2011Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	872500000	USD
CY2011Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	100000000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	16444100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	15233600000	USD
CY2012Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	14161000000	USD
CY2012Q2	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	15173300000	USD
CY2012Q2	us-gaap	Net Investment Income NetInvestmentIncome	169400000	USD
CY2012Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	70500000	USD
CY2012Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-600000	USD
CY2012Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	5900000	USD
CY2012Q2	us-gaap	Revenues Revenues	15407300000	USD
CY2012Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	12093100000	USD
CY2012Q2	us-gaap	Selling Expense SellingExpense	393000000	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1688800000	USD
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2081800000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	117600000	USD
CY2012Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	14358700000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1048600000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	405000000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	643600000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.96
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.94
CY2012Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2011Q2	us-gaap	Revenues Revenues	15100700000	USD
CY2011Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2700000	USD
CY2011Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	11922000000	USD
CY2011Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	8400000	USD
CY2011Q2	us-gaap	Net Investment Income NetInvestmentIncome	187800000	USD
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	305800000	USD
CY2011Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1605500000	USD
CY2011Q2	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	14879800000	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	701600000	USD
CY2011Q2	us-gaap	Selling Expense SellingExpense	405600000	USD
CY2011Q2	us-gaap	Interest Expense InterestExpense	103600000	USD
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.89
CY2011Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2011Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2011100000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1007400000	USD
CY2011Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	41500000	USD
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.92
CY2011Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	13913600000	USD
CY2011Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	14093300000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	338400000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.48
	us-gaap	Selling Expense SellingExpense	786300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3461200000	USD
	us-gaap	Interest Expense InterestExpense	226700000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.53
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5750
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	16800000	USD
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	30323500000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	23865000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4247500000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	28299500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1500100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2358400000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	28464100000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	177400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	858300000	USD
	us-gaap	Revenues Revenues	30822500000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-3400000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	23150000000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	27597700000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4087600000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	27560500000	USD
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	29534600000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-5100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	806300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3285000000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.40
	us-gaap	Interest Expense InterestExpense	209500000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2434500000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	10800000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.34
	us-gaap	Revenues Revenues	29995000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1628200000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	98600000	USD
	us-gaap	Selling Expense SellingExpense	802600000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	372600000	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6700000	USD
CY2012Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	59500000	USD
CY2011Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2011Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56600000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	118200000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	113400000	USD
CY2012Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	977500000	USD
CY2011Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	957700000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1973300000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1919700000	USD
CY2012Q2	us-gaap	Other Income OtherIncome	34800000	USD
CY2011Q2	us-gaap	Other Income OtherIncome	8500000	USD
	us-gaap	Other Income OtherIncome	50700000	USD
	us-gaap	Other Income OtherIncome	17200000	USD
CY2012Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	6500000	USD
CY2011Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	11100000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	20200000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	15900000	USD
CY2012Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	400000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-200000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	6300000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-1400000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	620800000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	85200000	USD
CY2011Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2011Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	300000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	5400000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	1400000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	793900000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	80200000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-4400000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	400000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	13000000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-700000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1597400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	98000000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-4300000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	700000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	13700000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	2400000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1747300000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-27100000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	-22800000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	92300000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	14400000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1744600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	71500000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	313300000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	77300000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	22700000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1600000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	466900000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-380400000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3600000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-101900000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	87600000	USD
	us-gaap	Depreciation Depreciation	47400000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	17900000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	187500000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	781300000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	7278900000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	5449400000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	875700000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	186600000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-700000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	18700000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	276100000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	95800000	USD
	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-106100000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	226000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1967200000	USD
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-10500000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	451100000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	300000000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	200000000	USD
	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-106100000	USD
	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	-23900000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1173600000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	189300000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	83700000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	22700000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25200000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-248500000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	215200000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	21000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-470200000	USD
	us-gaap	Depreciation Depreciation	47200000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	36100000	USD
	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-89700000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	6351100000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	58600000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	137600000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1456300000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-186200000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	100000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	36100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-89000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	111300000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4982900000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	702700000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	18900000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	258300000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-456200000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	60900000	USD
	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	71100000	USD
	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-89700000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	206600000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	61300000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	526600000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1204800000	USD
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	600900000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	14000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	108100000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	194900000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	183900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1509300000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1800000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	23100000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	72400000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1886700000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	146700000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1699800000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1788800000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	905300000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	300000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1722900000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1173600000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	191300000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	123100000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	23812600000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1456300000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	185800000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	263500000	USD
CY2011Q2	us-gaap	Stockholders Equity StockholdersEquity	24181300000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	97300000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	119100000	USD
CY2012Q2	wlp	Number Of Commercial Medical Members NumberOfCommercialMedicalMembers	33500000	pure
CY2012Q2	wlp	Number Of Individuals Members NumberOfIndividualsMembers	65000000	pure
CY2012Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	pure
CY2012Q2	wlp	Number Of Counties In State Of Kansas Company Does Not Serve NumberOfCountiesInStateOfKansasCompanyDoesNotServe	30	pure
	wlp	Number Of Counties In New York City Metropolitan Area Company Serves As Independent Licensee NumberOfCountiesInNewYorkCityMetropolitanAreaCompanyServesAsIndependentLicensee	10	pure
	us-gaap	Nature Of Operations NatureOfOperations	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">. Organization</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">References to the terms “we”, “our”, “us”, “WellPoint” or the “Company” used throughout these Notes to Consolidated Financial Statements refer to WellPoint, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are </font><font style="font-family:Times New Roman;font-size:10pt;">one of the </font><font style="font-family:Times New Roman;font-size:10pt;">largest</font><font style="font-family:Times New Roman;font-size:10pt;"> health benefits companies</font><font style="font-family:Times New Roman;font-size:10pt;"> in the United</font><font style="font-family:Times New Roman;font-size:10pt;"> States, serving </font><font style="font-family:Times New Roman;font-size:10pt;">33.5</font><font style="font-family:Times New Roman;font-size:10pt;"> medical members through our affiliated health plans and more than </font><font style="font-family:Times New Roman;font-size:10pt;">65.0</font><font style="font-family:Times New Roman;font-size:10pt;"> individuals through </font><font style="font-family:Times New Roman;font-size:10pt;">all</font><font style="font-family:Times New Roman;font-size:10pt;"> subsidiaries as of </font><font style="font-family:Times New Roman;font-size:10pt;">June 30</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">2012</font><font style="font-family:Times New Roman;font-size:10pt;">. We offer a broad spectrum of network-based managed care plans to large and small employer, individual, Medicaid and senior markets. Our managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service, or POS, plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, we provide a broad array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. We provide an array of specialty and other </font><font style="font-family:Times New Roman;font-size:10pt;">insurance</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">products and services such as</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">behavioral health benefit services, </font><font style="font-family:Times New Roman;font-size:10pt;">dental, vision, </font><font style="font-family:Times New Roman;font-size:10pt;">life and disability insurance benefits</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. </font><font style="font-family:Times New Roman;font-size:10pt;">We</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">also </font><font style="font-family:Times New Roman;font-size:10pt;">provide services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Fina</font><font style="font-family:Times New Roman;font-size:10pt;">lly, we sell contact lenses, </font><font style="font-family:Times New Roman;font-size:10pt;">eye</font><font style="font-family:Times New Roman;font-size:10pt;">glasses</font><font style="font-family:Times New Roman;font-size:10pt;"> and other ocular products</font><font style="font-family:Times New Roman;font-size:10pt;"> through our recently acquired 1-800 CONTACTS, Inc., or 1-800 CONTACTS, subsidiary.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are an independent licensee of the Blue Cross and Blue Shield Association, or BCBSA, an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California; the Blue Cross and Blue Shield, or BCBS, licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding </font><font style="font-family:Times New Roman;font-size:10pt;">30</font><font style="font-family:Times New Roman;font-size:10pt;"> counties in the Kansas City area), Nevada, New Hampshire, New York (as the BCBS licensee in </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> New York City metropolitan and surrounding counties and as the Blue Cross or BCBS licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross Blue Shield, or Empire Blue Cross (in our </font><font style="font-family:Times New Roman;font-size:10pt;">New York</font><font style="font-family:Times New Roman;font-size:10pt;"> service areas). We also serve customers throughout the country as UniCare</font><font style="font-family:Times New Roman;font-size:10pt;">, and in certain California, Arizona and Nevada markets through our CareMore Health Group, Inc., or CareMore, subsidiary</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">We are licensed to conduct insurance operations in all </font><font style="font-family:Times New Roman;font-size:10pt;">50</font><font style="font-family:Times New Roman;font-size:10pt;"> states through our subsidiaries.</font></p>
CY2012Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1154100000	USD
CY2012Q2	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1	-57600000	USD
CY2012Q2	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses1	-34500000	USD
CY2012Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	18621700000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	16440500000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1107100000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1	-129200000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses1	-41600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	17376800000	USD
CY2012Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	17559700000	USD
CY2012Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	18621700000	USD
CY2012Q2	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	2255	pure
CY2012Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2129400000	USD
CY2011Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	2352	pure
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2480000000	USD
CY2012Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	332200000	USD
CY2011Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	221	pure
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	356900000	USD
CY2012Q2	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	256	pure
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	732600000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	4678500000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	4067400000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	2907300000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	744500000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	4862000000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	4568500000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	4253200000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	3025000000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	4299900000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-400000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	255100000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	77700000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5725500000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	929900000	USD
CY2012Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	20413300000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1675800000	USD
CY2011Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	20025400000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	400000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-4800000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	139900000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	31100000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-10200000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-7400000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	18100000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
CY2012Q2	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	0	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	363600000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	2600000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-3100000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	47100000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
CY2011Q2	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-2600000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	167100000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	288500000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	12600000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-12300000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-122000000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	284800000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	15300000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-25000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	49900000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-12100000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-59600000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	19500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	105700000	USD
	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2010Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	388700000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	2000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	700000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	47100000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-4200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-39400000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-139500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	28900000	USD
	us-gaap	Fair Value Level1 To Level2 Transfers Amount FairValueLevel1ToLevel2TransfersAmount	0	USD
	us-gaap	Fair Value Level1 To Level2 Transfers Amount FairValueLevel1ToLevel2TransfersAmount	0	USD
	us-gaap	Fair Value Level2 To Level1 Transfers Amount FairValueLevel2ToLevel1TransfersAmount	0	USD
	us-gaap	Fair Value Level2 To Level1 Transfers Amount FairValueLevel2ToLevel1TransfersAmount	0	USD
	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2012Q2	us-gaap	Commercial Paper CommercialPaper	789300000	USD
CY2012Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	11334100000	USD
CY2012Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.386	pure
CY2011Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.304	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.364	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.331	pure
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2012	wlp	Expected Material Contribution ExpectedMaterialContribution	0	USD
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2012Q3	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	0
CY2012Q2	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.0037	pure
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2012-04-09
	us-gaap	Line Of Credit Facility Expiration Date LineOfCreditFacilityExpirationDate	2016-09-29
	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	100000000	USD
CY2012Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.0143	pure
CY2012Q2	us-gaap	Loss Contingency Range Of Possible Loss Minimum LossContingencyRangeOfPossibleLossMinimum	0	USD
CY2012Q2	us-gaap	Loss Contingency Range Of Possible Loss Maximum LossContingencyRangeOfPossibleLossMaximum	500000000	USD
CY2012Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-01-24
CY2011Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2011-02-22
CY2011Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2011-03-10
CY2012Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-03-09
CY2012Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-03-23
CY2011Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2011-03-25
CY2012Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	93500000	USD
CY2011Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	91100000	USD
CY2011Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	92800000	USD
CY2012Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	95800000	USD
CY2012Q2	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-05-16
CY2012Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-06-08
CY2012Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-06-25
CY2011Q2	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2011-05-17
CY2011Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2011-06-10
CY2011Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2011-06-24
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2011Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2012Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	17400000	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	20800000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	62.30
	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	67.52
	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	69.92
CY2012Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2012Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	3160200000	USD
	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	3160200000	USD
	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	667200000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1700000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-1800000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-1100000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18800000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15500000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	66.35
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	46.19
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	74.12
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.56
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	63.20
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	3.8	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	3.4	pure
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	121700000	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	120000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1800000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-2000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-200000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3600000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	66.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	48.57
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	63.01
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	65.21
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4000000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	56.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01410	pure
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	991700000	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	946700000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00400	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	4.1	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	4.0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.02840	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00379	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.81
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	327700000	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3500000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	331200000	shares
CY2011Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	366100000	shares
CY2011Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	5400000	shares
CY2011Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	371500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331300000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3800000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	335100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	370100000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	5300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	375400000	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10800000	shares
CY2011Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10100000	shares
	wlp	Potentially Dilutive Restricted Stock Units Contingent On Operating Results PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults	800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10500000	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	2297000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2204300000	USD

Files In Submission

Name	View Source	Status
0001193125-12-313785-index-headers.html	Edgar Link	pending
0001193125-12-313785-index.html	Edgar Link	pending
0001193125-12-313785.txt	Edgar Link	pending
0001193125-12-313785-xbrl.zip	Edgar Link	pending
d383349d10q.htm	Edgar Link	pending
d383349dex311.htm	Edgar Link	pending
d383349dex312.htm	Edgar Link	pending
d383349dex321.htm	Edgar Link	pending
d383349dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wlp-20120630.xml	Edgar Link	completed
wlp-20120630.xsd	Edgar Link	pending
wlp-20120630_cal.xml	Edgar Link	unprocessable
wlp-20120630_def.xml	Edgar Link	unprocessable
wlp-20120630_lab.xml	Edgar Link	unprocessable
wlp-20120630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELV
Elevance Health, Inc. Stock $elv

2012 Q2 Form 10-Q Financial Statement

#000119312512313785 Filed on July 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV Elevance Health, Inc. Stock $elv

2012 Q2 Form 10-Q Financial Statement

#000119312512313785 Filed on July 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV
Elevance Health, Inc. Stock $elv